Static export generated 2026-07-28 07:45Z from the private Meridian research build — every value keeps its own as-of timestamp and provenance label; search, filters and admin actions are inactive in this copy. Private academic review only — not for redistribution.
MERIDIAN Regulatory & Corporate Impact Intelligence — personal research build
Data coverage is not complete: 3 source(s) failing; 24 open coverage incident(s); 1 source(s) awaiting credentials; 3 source(s) unverified. Details on the Source Health page — gaps are shown, never concealed.

Lennox International

Identity (GLEIF Global LEI Index)

FieldValueClass
Legal nameLennox InternationalSF
LEIUnavailableSF
Swiss UIDNot in GLEIF recordSF
JurisdictionUnavailableSF
Legal addressUnavailableSF
HeadquartersRichardson, Texas SF
Entity statusUnavailableSF
Geneva connectionunresolvedCM

Listed securities (SIX Swiss Exchange issuer directory)

ISINTickerMICShare classSegmentAccounting standardNext GMAuditorProv.
LIIBuilding Productsnot announced

Market snapshot

543.93 USD
Stale — 10 days old · delayed per exchange agreement · yahoo

MetricValueClass
SMA 20553.93CM
SMA 50527.35CM
52-week range position47% of range 437.87–664.54CM
Trend (SMA20 vs SMA50)upCM
History depth261 daily barsSF

Analyst price targets

LowMeanMedianHighAnalystsProviderAs of
NoneNoneNoneNone23finnhub_recs2026-07-17T21:35:04Z

Financials (latest reported period)

Most recent reported income-statement figures (company disclosure redistributed by the named source); absent figures stay absent — never estimated.

Period ending 2025-12-31 (annual) · reported in USD

MetricValueClass
Revenue5.2B USDSF
Gross profit1.7B USDSF
Operating income1.1B USDSF
EBITDA1.2B USDSF
Net income805.8M USDSF
EPS22.79SF

Recent company events

News, insider transactions, congressional trading disclosures and analyst-estimate snapshots from connected sources, each with provenance. Analyst estimates are forecasts — never price targets.

WhenKindEventProvenance
2026-07-17newsLennox International (LII) Looks Fairly Valued After A 15% 3 Month Gain
2026-07-16newsCarrier Global: Valuation Frontrunning Elusive Growth
2026-07-14news1 Mid-Cap Stock with Promising Prospects and 2 We Avoid
2026-07-02newsGet Paid 11% A Year To Hold TT Stock You Already Own
2026-07-02newsIs Everus Construction Group, Inc. (ECG) Outperforming Other Construction Stocks This Year?
2026-07-01newsWhat to Expect From Lennox International's Q2 2026 Earnings Report
2026-05-28insiderInsider transaction (SEC Form 4): NORRIS JOHN W III, Form 4 code G (gift), -990 shares
2026-05-26insiderInsider transaction (SEC Form 4): Somasundaram Sivasankaran, Form 4 code D, -343 shares
2026-05-21insiderInsider transaction (SEC Form 4): Somasundaram Sivasankaran, Form 4 code A (award), +343 shares
2026-05-21insiderInsider transaction (SEC Form 4): NORRIS JOHN W III, Form 4 code A (award), +343 shares
2026-05-21insiderInsider transaction (SEC Form 4): Embree Tracy A, Form 4 code A (award), +343 shares
2026-05-21insiderInsider transaction (SEC Form 4): Wall Shane D, Form 4 code A (award), +343 shares
1 further data field this platform tracks — no connected source covers this issuer yet. Shown to demonstrate capacity; each populates automatically when a source does, and nothing is estimated in the meantime. Show what is tracked ›

Segment & geographic revenue (company disclosures)

Figures parsed from filings and redistributed by the named provider; values are shown as reported and shares are Calculated Metrics with the formula in the column header.

No disclosed segment or geographic revenue ingested for this company yet. The Business Quant pipeline (SEC-parsed company disclosures) reaches US-listed issuers progressively within its daily budget; issuers that do not disclose segment detail keep this honest state.

How the company makes money

Business description and sector are sourced facts (Yahoo assetProfile / Wikidata / Wikipedia — source named per value); the registry-disclosed purpose follows. Disclosed segment/geographic revenue appears in the card above when the issuer reports it; official EDGAR-XBRL and ESEF facts feed the financials card since 2026-07-07. Nothing is estimated in the meantime.

Sector: Industrials peers

Registry-disclosed purpose: Access currently requires credentials — the Swiss registry (Zefix) API returned HTTP 401 anonymously (verified 2026-07-02); registered-purpose text will populate once free Zefix credentials are configured in .env.

Regulators of highest concern

Ranked by maximum applicability of evidence-backed matches; when none exist yet, the jurisdictional supervision context derived from listing venue/domicile is shown instead — labelled, never asserted as a match.

AuthorityJur.MatchesMax applicabilityMax confidence
EU Publications Office (EU law)EU100.700.78
us_congressUS60.700.78
General Services AdministrationUS10.700.78

Regulatory exposure — matches with evidence

The price-impact column is a LABELLED INFERENCE (EBI): reasoning about whether and why the exposure could bear on the share price, derived from the regulation's type, region and topic and the match layer/direction. It is not an asserted fact and states no magnitude; the Applicability/Confidence/Exposure figures and the linked evidence remain the sourced basis.

RuleInstrumentRelationshipApplicabilityConfidenceExposurePotential price impact (inference)Review
R-SECTOR-TARIFFS_TRADE_REMEDIESGeneral Services Acquisition Regulation; Acquisition of Information and Communication Techsector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a US tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed. The measure is proposed / not yet in force, so any impact would be prospective and contingent on adoption.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESCELEX:32026R1022R(01): Corrigendum to Commission Delegated Regulation (EU) 2026/1022 of 30sector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a EU tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESCELEX:32026R1022: Commission Delegated Regulation (EU) 2026/1022 of 30 April 2026 amendingsector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a EU tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESCELEX:32026R1457: Commission Implementing Regulation (EU) 2026/1457 of 29 June 2026 on thesector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a EU tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESCELEX:32026R1461: Regulation (EU) 2026/1461 of the European Parliament and of the Council sector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a EU tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESCELEX:32026R1455: Regulation (EU) 2026/1455 of the European Parliament and of the Council sector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a EU tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESCELEX:32026R1463: Council Regulation (EU) 2026/1463 of 25 June 2026 amending Regulation (Esector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a EU tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESCELEX:32026R1465: Council Regulation (EU) 2026/1465 of 25 June 2026 amending Regulation (Esector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a EU tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESCELEX:32026R1422: Commission Implementing Regulation (EU) 2026/1422 of 25 June 2026 amendisector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a EU tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESCELEX:32026R1540: Commission Implementing Regulation (EU) 2026/1540 of 6 July 2026 imposinsector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a EU tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESHR 9601 (119th Congress): To direct the United States Trade Representative to initiate invsector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a US tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed. The measure is proposed / not yet in force, so any impact would be prospective and contingent on adoption.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESS 4883 (119th Congress): A bill to amend the Export Control Reform Act of 2018 to increasesector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a US tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed. The measure is proposed / not yet in force, so any impact would be prospective and contingent on adoption.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESS 4840 (119th Congress): Export Control Enforcement and Enhancement Actsector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a US tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed. The measure is proposed / not yet in force, so any impact would be prospective and contingent on adoption.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESHR 8169 (119th Congress): Export Control Enforcement and Enhancement Actsector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a US tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed. The measure is proposed / not yet in force, so any impact would be prospective and contingent on adoption.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESHR 4326 (119th Congress): To require the Congressional Budget Office to conduct an economisector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a US tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed. The measure is proposed / not yet in force, so any impact would be prospective and contingent on adoption.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESHR 8770 (119th Congress): SAFEGUARDS Act of 2026sector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a US tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed. The measure is proposed / not yet in force, so any impact would be prospective and contingent on adoption.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review
R-SECTOR-TARIFFS_TRADE_REMEDIESCELEX:32026D1760: Political and Security Committee Decision (CFSP) 2026/1760 of 14 July 20sector_topic_candidate_tariffs_trade_remedies0.700.78Insufficient evidence to calculateEBI Limited direct impact. An indirect topical (candidate) link to a EU tariff / trade-remedy measure: if it applied it could raise input or import costs, or restrict cross-border revenue, but any effect would be indirect and is unconfirmed.
Inference from the match's regulation type, region and topic — not an asserted fact; no magnitude implied.
needs_review

Recent filings — potential impact inputs

A filing flags potential impact only via evidence-backed matching between its disclosed content and tracked measures.

FiledFormTitleDocument
2026-05-288-K8-K — LENNOX INTERNATIONAL INCdocument
2026-04-2910-Q10-Q — LENNOX INTERNATIONAL INCdocument
2026-04-298-K8-K — LENNOX INTERNATIONAL INCdocument
2026-02-1710-K10-K — LENNOX INTERNATIONAL INCdocument
2026-01-288-K8-K — LENNOX INTERNATIONAL INCdocument
2025-12-058-K8-K — LENNOX INTERNATIONAL INCdocument
2025-10-2210-Q10-Q — LENNOX INTERNATIONAL INCdocument
2025-10-228-K8-K — LENNOX INTERNATIONAL INCdocument
2025-07-2310-Q10-Q — LENNOX INTERNATIONAL INCdocument
2025-07-238-K8-K — LENNOX INTERNATIONAL INCdocument